November 7th 2019
Today our sequencing team at the ICG participated in the
Nanopore Sequencing Day at the EMBL in Heidelberg. We’ve heard fantastic talks about
the usage and possibilities of the third groundbreaking sequencing technology. Whole
genome sequencing combined with transcriptomics and epigenomic analyses will certainly
accelerate our research in the field of cardiovascular diseases.
FH, MM, TR
Comments
Post a Comment